Comments on ‘Genotypic diversity of the Helicobacter pylori vacA c region and its correlation with gastric disease outcomes’
Masoud Keikha

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHelicobacter pylori-related gastroenterology studies · Veterinary medicine and infectious diseases · Gastric Cancer Management and Outcomes
Dear editor
The recent study by Khadir et al. [1] titled ‘Genotypic diversity of the Helicobacter pylori vacA c region and its correlation with gastric disease outcomes’ provides valuable insights into the association between H. pylori vacA c-region genotypes and gastric disease outcomes in a Moroccan cohort. Notably, the study reports a significant association between the vacA c1 allele and an increased risk of gastric cancer (GC). However, several issues should be considered to contextualize these findings and guide future research.
Limited functional characterization of vacA c-region
While the study identifies correlations between vacA c-region genotypes and disease outcomes, it does not delve into the functional implications of these genotypic variations. The vacA gene’s other regions, such as the signal (s), middle (m), intermediate (i) and deletion (d) regions, have been extensively studied for their roles in H. pylori pathogenicity [2]. However, the specific contribution of the c-region to the bacterium’s virulence mechanisms remains unclear. Functional studies are necessary to elucidate how variations in the vacA c-region influence H. pylori pathogenicity and interaction with host tissues. To address this gap, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-based gene editing could be employed to create isogenic H. pylori strains with specific vacA c-region variants. These strains could then be tested in cellular or animal models to assess their effects on host cell vacuolation, apoptosis and immune response modulation. Additionally, computational modelling of the vacA protein structure could help predict how c-region variations alter toxin activity or host receptor binding. For example, prior studies using CRISPR/Cas to investigate H. pylori virulence factors, such as cagA, have successfully elucidated functional mechanism [3].
Potential confounding factors
The study does not account for other H. pylori virulence factors, such as the presence of the cagA gene, which have been associated with severe gastric diseases [4]. The interplay between multiple virulence factors may modulate the bacterium's overall pathogenic potential. Additionally, host genetic factors (e.g. polymorphisms in IL-1β or TNF-α genes) and environmental influences (e.g. diet, smoking or socioeconomic status), which were not considered in the study, could confound the observed associations. To integrate these confounders into future analyses, multivariate regression models could be employed to adjust for host and environmental variables. For instance, studies by El-Omar et al. [5] have demonstrated the importance of incorporating host genetic polymorphisms when assessing H. pylori-related disease risk. Environmental factors could be assessed using standardized questionnaires or biomarkers, as seen in studies linking high-salt diets to H. pylori virulence [6].
Cross-sectional study design
The cross-sectional nature of the study limits the ability to infer causal relationships between vacA c-region genotypes and gastric disease outcomes. Longitudinal studies tracking individuals over time are necessary to establish temporal associations and causality. Such studies would provide stronger evidence for the role of specific vacA c-region genotypes in the progression from H. pylori infection to gastric pathology. Prospective cohort studies could be designed to follow individuals with H. pylori infection over decades, monitoring changes in vacA genotypes and disease outcomes. For example, the Shandong Intervention Trial successfully used a longitudinal design to demonstrate the long-term benefits of H. pylori eradication in reducing GC incidence [7]. Similarly, nested case-control studies within large cohorts could provide insights into the temporal dynamics of vacA c-region variations and disease progression.
Methodological considerations
The detection of multiple infections, indicated by the presence of both vacA c1 and c2 alleles in some samples, suggests the possibility of mixed H. pylori populations within individual hosts [8]. This could complicate the interpretation of genotype–disease associations. Advanced molecular techniques, such as deep sequencing or single-cell genomics, should be employed in future studies to accurately characterize the genetic diversity of H. pylori within hosts and its clinical implications. For instance, deep sequencing has been successfully used in studies by Kennemann et al. [9] to resolve mixed H. pylori infections and track strain evolution within hosts. Single-cell genomics could further elucidate the heterogeneity of H. pylori populations and their functional consequences at the cellular level.
Conclusion
While Khadir et al.’s study contributes to understanding the potential role of vacA c-region genotypes in gastric disease outcomes, addressing these limitations through further research is crucial. Future studies should aim for broader population inclusion, functional analyses of vacA c-region variants, consideration of additional bacterial and host factors, longitudinal designs and refined methodological approaches to validate and expand upon these findings. By integrating these suggestions, researchers can provide a more comprehensive understanding of the vacA c-region’s role in H. pylori-associated gastric diseases.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1El Khadir M Zahir SO Boukhris SA Benajah DA Ibrahimi SA et al Genotypic diversity of the Helicobacter pylori vac A c region and its correlation with gastric disease outcomes J Med Microbiol 20257400196910.1099/jmm.0.00196940052666 PMC 11936344 · doi ↗ · pubmed ↗
- 2Sharndama HC Mba IE Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms Braz J Microbiol 202253335010.1007/s 42770-021-00675-034988937 PMC 8731681 · doi ↗ · pubmed ↗
- 3Zhang XS Tegtmeyer N Traube L Jindal S Perez-Perez G et al A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori Cag A epithelial cell interactions P Lo S Pathog 201511 e 100462110.1371/journal.ppat.100462125646814 PMC 4412286 · doi ↗ · pubmed ↗
- 4Ouali AB Unraveling Cag A’s potential: a promising frontier for gastric cancer Gastroenterol Funct Med 2023110.54844/gfm.2023.435 · doi ↗
- 5El-Omar EM Carrington M Chow WH Mc Coll KE Bream JH et al Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 200040439840210.1038/3500608110746728 · doi ↗ · pubmed ↗
- 6Gaddy JA Radin JN Loh JT Zhang F Washington MK et al High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infection and immunity Infect Immun 2013812258226710.1128/IAI.01271-1223569116 PMC 3676043 · doi ↗ · pubmed ↗
- 7Wong BC-Y Lam SK Wong WM Chen JS Zheng TT et al Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial JAMA 200429118719410.1001/jama.291.2.18714722144 · doi ↗ · pubmed ↗
- 8Xiao W Ma ZS Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development Helicobacter 202227 e 1289910.1111/hel.1289935678078 · doi ↗ · pubmed ↗
